Javascript must be enabled to continue!
Abstract P208: Metabolomic Profiles Associated With Blood Pressure Reduction in Response to the DASH and DASH-Sodium Trials
View through CrossRef
Introduction:
The Dietary Approaches to Stop Hypertension (DASH) diet significantly reduced blood pressure (BP) in the DASH and DASH-Sodium trials, but the underlying mechanisms are unclear.
Hypothesis:
We hypothesized that certain metabolites will be associated with BP reductions.
Methods:
Metabolomic profiling was conducted at the end of the diet interventions for participants randomly assigned to the DASH or control diet in multicenter, controlled feeding studies: DASH (N=219) and DASH-Sodium trials (N=395). Using multivariable linear regression models to examine the association between metabolites and BP change, we tested for interactions between diet and metabolites for the following comparisons: 1) DASH vs. control diets in the DASH trial, 2) DASH-high sodium vs. control-high sodium diets in the DASH-Sodium trial, and 3) DASH-low sodium vs. control-high sodium diets in the DASH-Sodium trial. Pathway overrepresentation analysis was constructed for significant metabolites.
Results:
Identified were 65 significant interactions [DASH=12; DASH-high sodium=35; DASH-low sodium=18]. Most amino acids (16/19), cofactors and vitamins (15/15), xenobiotics (9/13), peptides (4/5), and a nucleotide (1/1) were higher in participants consuming the DASH diets vs. the control diets. These metabolites were associated with BP reductions in participants consuming the DASH diets, but not control diets (
Figure
). Many lipid metabolites (10/12) were lower in participants consuming the DASH vs. the control diets. Lipid concentrations were associated with BP elevations in participants consuming the DASH diets and with BP reductions in participants consuming the control diets. Metabolites associated with tocopherol metabolism, ceramides, and pantothenate and CoA metabolism were overrepresented.
Conclusions:
Using data from randomized feeding studies, we identified metabolites that were associated with BP lowering. These metabolites highlight the pathways through which DASH diet reduced BP.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract P208: Metabolomic Profiles Associated With Blood Pressure Reduction in Response to the DASH and DASH-Sodium Trials
Description:
Introduction:
The Dietary Approaches to Stop Hypertension (DASH) diet significantly reduced blood pressure (BP) in the DASH and DASH-Sodium trials, but the underlying mechanisms are unclear.
Hypothesis:
We hypothesized that certain metabolites will be associated with BP reductions.
Methods:
Metabolomic profiling was conducted at the end of the diet interventions for participants randomly assigned to the DASH or control diet in multicenter, controlled feeding studies: DASH (N=219) and DASH-Sodium trials (N=395).
Using multivariable linear regression models to examine the association between metabolites and BP change, we tested for interactions between diet and metabolites for the following comparisons: 1) DASH vs.
control diets in the DASH trial, 2) DASH-high sodium vs.
control-high sodium diets in the DASH-Sodium trial, and 3) DASH-low sodium vs.
control-high sodium diets in the DASH-Sodium trial.
Pathway overrepresentation analysis was constructed for significant metabolites.
Results:
Identified were 65 significant interactions [DASH=12; DASH-high sodium=35; DASH-low sodium=18].
Most amino acids (16/19), cofactors and vitamins (15/15), xenobiotics (9/13), peptides (4/5), and a nucleotide (1/1) were higher in participants consuming the DASH diets vs.
the control diets.
These metabolites were associated with BP reductions in participants consuming the DASH diets, but not control diets (
Figure
).
Many lipid metabolites (10/12) were lower in participants consuming the DASH vs.
the control diets.
Lipid concentrations were associated with BP elevations in participants consuming the DASH diets and with BP reductions in participants consuming the control diets.
Metabolites associated with tocopherol metabolism, ceramides, and pantothenate and CoA metabolism were overrepresented.
Conclusions:
Using data from randomized feeding studies, we identified metabolites that were associated with BP lowering.
These metabolites highlight the pathways through which DASH diet reduced BP.
Related Results
Metabolomic Profiles Associated With Blood Pressure Reduction in Response to the DASH and DASH-Sodium Dietary Interventions
Metabolomic Profiles Associated With Blood Pressure Reduction in Response to the DASH and DASH-Sodium Dietary Interventions
Background:
The DASH (Dietary Approaches to Stop Hypertension) diets reduced blood pressure (BP) in the DASH and DASH-Sodium trials, but the underlying mechanisms are u...
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED]Guardian Blood Balance Reviews (Works Or Hoax) Does Guardian Botanicals Blood Balance AU Really Works? Read Updated Report! Diabetes and Hypertension is such a health p...
Serum protein responses to Dietary Approaches to Stop Hypertension (DASH) and DASH-Sodium trials and associations with blood pressure changes
Serum protein responses to Dietary Approaches to Stop Hypertension (DASH) and DASH-Sodium trials and associations with blood pressure changes
Objectives:
The Dietary Approaches to Stop Hypertension (DASH) diet reduces blood pressure, but the mechanisms underlying DASH diet-blood pressure relations are not wel...
Urine Metabolites Associated with the Dietary Approaches to Stop Hypertension (DASH) Diet: Results from the DASH‐Sodium Trial
Urine Metabolites Associated with the Dietary Approaches to Stop Hypertension (DASH) Diet: Results from the DASH‐Sodium Trial
ScopeSerum metabolomic markers of the Dietary Approaches to Stop Hypertension (DASH) diet are previously reported. In an independent study, the similarity of urine metabolomic mark...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
Blood Cross Matching Without Anti-Human Globulin (AHG) and Bovine Serum: A New Interest for an Old Idea
Blood Cross Matching Without Anti-Human Globulin (AHG) and Bovine Serum: A New Interest for an Old Idea
Abstract
Introduction
Transfusion medicine promotes the safety of blood transfusions by rigorously testing to eliminate risks of infection and hemolytic. The efficacy (to correct ...
Design of new resource allocation scheme for symbiosis of DASH clients and non-DASH clients
Design of new resource allocation scheme for symbiosis of DASH clients and non-DASH clients
AbstractIn this paper, we propose a new resource allocation scheme for symbiosis of DASH clients and non-DASH clients (RASS) to provide seamless video streaming service to DASH cli...
THE IMPACT OF THE DASH AND MEDITERRANEAN DIETS ON BLOOD PRESSURE AND CARDIOVASCULAR RISK FACTORS: A REVIEW OF SCIENTIFIC EVIDENCE AND PRACTICAL IMPLICATIONS
THE IMPACT OF THE DASH AND MEDITERRANEAN DIETS ON BLOOD PRESSURE AND CARDIOVASCULAR RISK FACTORS: A REVIEW OF SCIENTIFIC EVIDENCE AND PRACTICAL IMPLICATIONS
Introduction: Hypertension is one of the major risk factors for premature mortality and cardiovascular diseases. Lifestyle modifications, including diet, play a crucial role in its...


